Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PPP1R14B antisense RNA 1 (PPP1R14B-AS1) is a long non-coding RNA (lncRNA) transcribed antisense to the PPP1R14B gene. It is not a protein-coding gene but is implicated in the regulation of gene expression at both transcriptional and post-transcriptional levels. Elevated PPP1R14B-AS1 levels have been repeatedly documented in various tumor types, where its overexpression is correlated with poor patient prognosis. Functional studies show that PPP1R14B-AS1 promotes tumor cell proliferation and migration, especially in liver cancer, lung adenocarcinoma, and breast cancer. Mechanistically, it acts as a miRNA sponge for miR-134-3p, leading to upregulation of downstream targets such as LASP1, and enhances mitochondrial respiration without affecting glycolysis. Knockdown of PPP1R14B-AS1 reduces proliferation and migration of cancer cells, positioning it as a potential oncogenic biomarker and possible therapeutic target in oncology[1][2][4][6].
Acts as a competing endogenous RNA for microRNA-134-3p, modulating expression of LASP1; Enhances mitochondrial respiration by increasing basal respiration and ATP production.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PPP1R14B antisense RNA 1 (PPP1R14B-AS1).